Product Introduction:
Megapime XP 500/62.5 mg Injection contains a powerful combination of Cefepime 500 mg, a fourth-generation cephalosporin antibiotic, and Tazobactam 62.5 mg, a beta-lactamase inhibitor. This combination is used in hospital settings for treating severe bacterial infections, especially when resistance to other antibiotics is suspected.
Uses:
-
Lower respiratory tract infections (pneumonia, bronchitis)
-
Urinary tract infections (including complicated cases)
-
Skin and soft tissue infections
-
Intra-abdominal infections
-
Septicemia (blood infections)
-
Hospital-acquired infections
Benefits:
-
Broad and enhanced antibacterial coverage
-
Effective against drug-resistant Gram-negative and Gram-positive organisms
-
Suitable for serious systemic infections
-
Fast intravenous action
Composition:
-
Cefepime 500 mg
-
Tazobactam 62.5 mg
Side Effects:
-
Injection site reactions (pain, swelling)
-
Nausea or vomiting
-
Diarrhea
-
Allergic reactions (rash, itching, anaphylaxis)
-
Headache
-
Elevated liver enzymes
-
Rare: seizures in high doses or renal impairment
Safety Advice:
-
Route: For IV use only – must be administered by healthcare professional
-
Pregnancy: Use with caution and only under medical supervision
-
Breastfeeding: Consult a doctor; minimal transfer in breast milk
-
Renal Impairment: Dose adjustment may be necessary
-
Allergy Warning: Contraindicated in patients allergic to cephalosporins or penicillins
-
Storage: Store below 25°C, protect from moisture and light; use reconstituted solution immediately
